Clinical trial
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children…
NCT00145626 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00145626 |
|---|---|
| Title | HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies |
| Official title | HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | Assisi Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplasia, Chronic Myeloid Leukemia, Histiocytosis |
| Intervention type | Device, Drug, Procedure |
| Interventions | Chemotherapy and antibodies, Miltenyi Biotec CliniMACS, Allogeneic stem cell transplantation |
| Enrollment | 40 |
| Start date | May 1, 2004 |
| Primary completion | Mar 1, 2015 |
| Completion | Jul 1, 2016 |
| First posted | Sep 5, 2005 |
| Last update posted | Jun 19, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: